Bioequivalence Study of Generic Celecoxib 200 mg Capsules - Trial NCT06337422
Access comprehensive clinical trial information for NCT06337422 through Pure Global AI's free database. This Phase 1 trial is sponsored by International Bio service and is currently Not yet recruiting. The study focuses on Healthy Volunteer. Target enrollment is 40 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
International Bio service
Timeline & Enrollment
Phase 1
Sep 23, 2024
Oct 04, 2024
Primary Outcome
Bioequivalence based on Cmax period,Bioequivalence based on AUC parameters
Summary
To determine and compare the rate and extent of absorption of a test formulation with that of
 a reference innovator formulation when given as equal labeled dose in healthy subjects under
 fasting conditions
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT06337422
Non-Device Trial